VITAL is a BARDA Accelerator Network (BAN) Hub supporting the development and acceleration of next-generation therapeutic & vaccine platforms and technologies to promote health security.
Start2 Group is a global innovation leader taking startups to the next level in development and commercialization. As a premier startup ecosystem partner, Start2 Group serves as the destination for startups, governments, investors, and corporations to shape and scale ventures with growth potential. We operate in key markets across North and South America, Europe, and Asia, shaping the future of innovation on a global scale.
ACI accelerates international life science startups by providing individualized high-level strategic guidance, tactical, and operational assistance, and fundraising support.
BioLabs provides a comprehensive innovation support platform that offers access to fully-equipped co-working laboratory facilities, programming, and connections to a global network of collaborators & capital partners.
Established by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS), the BARDA Accelerator Network (BAN) fosters the growth of health security innovation ecosystems globally and accelerates the development and commercialization of next-generation health security solutions.
Established by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS), the BARDA Accelerator Network (BAN) fosters the growth of health security innovation ecosystems globally and accelerates the development and commercialization of next-generation health security solutions.
